Alzheimers Research on SARRP Leads to Phase 1 Clinical Study
In this study, Low Dose Brain Irradiation Reduces
Amyloid-ß and Tau in 3xTg-AD Mice, the researchers used the SARRP to deliver hemi-brain irradiations with a 2-beam treatment plan. The variable collimator made it possible to adjust the treatment beam size to each mouse. The preclinical results have led to a phase 1 clinical study.
See more from Dr. Wilson’s and the rest of the team’s research below, and find the full article here.